Important risk minimization information for healthcare professionals prescribing Olumiant (baricitinib) for treatment of Atopic Dermatitis

This guide contains important information to assist clinicians in their initial discussion with patients when prescribing baricitinib, covering pregnancy and breast feeding, infections, changes in lipid parameters, and venous thromboembolism.

Source:

Eli Lilly